key: cord-1003673-dvua8ncy
authors: Fusco, Francesco Maria; Pisaturo, Mariantonietta; Iodice, Valentina; Bellopede, Raffaele; Tambaro, Orsola; Parrella, Giovanni; Di Flumeri, Giusy; Viglietti, Rosaria; Pisapia, Raffaella; Carleo, Maria Aurora; Boccardi, Martina; Atripaldi, Luigi; Chignoli, Bruno; Maturo, Nicola; Rescigno, Carolina; Esposito, Vincenzo; Dell’Aversano, Raffaele; Sangiovanni, Vincenzo; Punzi, Rodolfo
title: COVID-19 infections among Healthcare Workers in an Infectious Diseases specialized setting in Naples, Southern Italy: results of a cross-sectional surveillance study
date: 2020-06-18
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2020.06.021
sha: 35ecf93e430da05640ab8eddd065ebf4346e9070
doc_id: 1003673
cord_uid: dvua8ncy

We performed a surveillance study for COVID-19 in March-April 2020 among asymptomatic HCWs in a specialized Infectious Diseases hospital in Naples, Italy. All HCWs underwent two rounds of molecular and serology testing for SARS-CoV-2. 115 HCWs were tested: two infections were identified by PT-PCR and two HCWs were SARS-CoV-2 IgG seropositive. The overall prevalence of current or probable-previous infection was 3.4%. The infection rate among HCWs is reasonable low. Most of the infected HCWs had been asymptomatic, which supports the need for periodic screening of HCWs for COVID-19.

Since the beginning of COVID-19 epidemic, hospital-associated transmission has been recognized as an important route of spread [1, 2] . According to preliminary data from China, healthcare workers (HCWs) facing COVID-19 represent a high-risk category [1, 3] . This is also confirmed in early reports from Italy, where HCWs have represented 9% of total cases [4] .

Few data are available about the number of asymptomatic patients and their role in disease transmission. Recent data suggest that transmission of SARS-CoV-2 occurs before the onset of symptoms [5] . These data are even more important in HCWs, where knowledge about transmission dynamics is scanty. In particular, understanding the rate of infected HCWs, including asymptomatic infections, is essential to reduce nosocomial spreading.

In March 2020, a serology test for IgG and IgM anti-COVID-19 determination became available.

Antibody tests, while not useful for diagnostic purposes because of the time needed for the immune response, may reveal patients who have had very mild or asymptomatic infections [6] . Thus, these tests can be useful for seroprevalence study among at-risk population, such as HCWs.

We report the results of a cross-sectional surveillance study conducted from March 23 to April 2, 2020 among HCWs working in a mono-specialist Infectious Diseases setting, the "D. Cotugno" hospital in Naples, Southern Italy. The aim of the study was to understand the prevalence of active and asymptomatic infection among HCWs, and to verify the appropriateness of infection control measures in place.

We conducted a cross-sectional surveillance study among HCWs working with suspected and confirmed COVID-19 patients.

The study setting is the Emergency Department (ED), and two Medical Divisions ("First" and "Third" Division) of the "D. Cotugno" hospital in Naples, Southern Italy. The "D. Cotugno" is a Moreover, given the high workload in ED, Medical Doctors from other Divisions performed some shifts in ED in order to support the colleagues: for this reason, we included in the study all Medical Doctors of other Divisions who performed at least one shift in the ED in the study period. Inclusion criteria were fulfilling of surveillance test according to study protocol, being asymptomatic at the moment of surveillance, and consent for the use of personal data. No exclusion criteria were applied.

The surveillance tests were performed in the period from March 23 to April 2, 2020 (surveillance period). Participants underwent two nasopharyngeal swabs for the RT-PCR of SARS CoV-2 RNA, and two serology tests for SARS CoV-2 specific IgM and IgG. The tests were performed in all HCWs in the period March 23-26, 2020 and repeated on March 30-April 2, 2020. For each HCW, the two tests were performed 6-7 days apart. Moreover, a standardized form was been filled in by all participants, exploring variables about their role, the level and duration of exposure to COVID-19 patients, years of experience, and participation to training events about personal protective equipment (PPE) use. We also explore the presence of any symptoms in the previous 30 days.

We define as outcomes the presence of COVID-19 infection, defined as a positive molecular RT-PCR at nasopharyngeal swab, irrespectively of serology results, and the presence of a probable previous infection, defined as the positivity of specific IgG, with negative RT-PCR at nasopharyngeal swab.

Molecular test were performed using a RT-PCR targeted to specific SARS CoV-2 ORF-1a/b and Egene regions (Roche's cobas 6800/8800 Systems), while IgM/IgG serology tests were performed using a chemiluminescence testing method (MAGLUMI™ 2000 Plus 2019-nCov IgM and IgG assays, Snibe, China). 5 Descriptive analysis of the data has been performed. The outcomes have been correlated with different variables using chi-square and t-student tests, where appropriate, with a statistical level of significance of p < 0,05. The statistical software Stat Calc, Version 9, has been used.

Out of 120 eligible participants, 115 HCWs were included in the study. The remaining 5 underwent surveillance tests but did not complete the standardized form and did not give the consent to the use of personal data. The main characteristics of study population are summarized in Table 1 . Most of HCWs had at least one year of work experience at "D. Cotugno" hospital. Among those with less than 1 year of work period, many have been hired very recently in response to COVID-19 epidemic.

Almost all participated in institutional training events about the use of PPE. Among those who did not participate in training events, most (8 out of 13, 62%) were Medical Doctors, and the remaining were very recently hired.

Few HCWs reported mild symptoms in the 30 days before the surveillance period: 6 (5%) reported a mild influenza-like illness, while other 2 (1,7%) reported other symptoms (sore throat, rhinitis).

All HCWs included in the study were asymptomatic at the time of specimen collection.

Two out of 115 (1.7%) HCWs had a positive molecular test on round one of testing. After 6-7 days, all 113 initially negative HCWs were negative on repeat molecular testing. Two out of the 115 HCWs had IgG antibodies at a significant titre (higher that 30, upper normal value 1). All HCWs were negative for IgM antibodies. The two HCWs with positive molecular tests were both seronegative, and no HCW seroconverted between the first and second samples.

Overall therefore, two COVID-19 infections, and two probable previous infections were identified, giving an overall prevalence of 3.4%.

Among explored variables, none resulted significantly associated with ongoing or probable previous infection. All staff with confirmed or probable COVID-19 (4/4, 100%) had more than 1 year of experience at "D. Cotugno" hospital compared to 65/111 (58.5%) without COVID-19, although this was not statistically significant (p=0.096).

A brief epidemiological investigation was conducted among the positive cases. The probable previous infections occurred in a nurse and a careworker working at ED. One reported mild flu-like symptoms some weeks before. The cases positive at molecular test occurred in a Medical Doctor working both in the Medical Division and in ED as supporting staff, and in a nurse working in the Third Medical Division. After the diagnosis, one developed mild symptoms, and the other remained 6 asymptomatic. No clear exposure event occurred, and no significant breakages of Infection Control procedures were reported. According to epidemiological investigation, no close contacts occurred between cases, except for the two probable previous infections, constantly working together in the same shift.

The key finding of the study is an overall prevalence of COVID-19 in the study population of 3.4%.

To the best of our knowledge, our study is the first reporting infection prevalence among asymptomatic HCWs for COVID-19 in a specialized setting. Recent studies from the Netherlands and UK reported prevalences of 9% and 18% in HCWs, respectively. However, both studies were performed in general hospital settings, using molecular test only to test symptomatic staff [7, 8] .

In the absence of comparative data from similar settings, we believe that the rate of infected HCWs is acceptably low. The fact that some infected HCWs had always been asymptomatic supports the need for a periodic screening for COVID-19 among HCWs, in order to promptly remove from workplace potentially infectious HCWs. Epidemiological investigation failed to identify the modes of exposure. Accordingly, we cannot exclude acquisition of the infections in the community instead than within hospital. In at least one case, other family members of the HCW were affected by COVID-19 in the same period, making intra-familial transmission likely. The absence of detection of any new cases between the two sampling periods may help define an appropriate retesting interval in hospitals considering periodic sampling of HCWs. It also helps provide assurance about the reliability of a single nasopharyngeal sample at a point in time as a proxy for the individual's true COVID-19 status.

A limitation of this study is the low number of involved HCWs, meaning that the study was not powered to identify risk factors for infection of HCWs. We involved HCWs from ED, First and Third divisions only, because they shared the same level of exposure and faced to similar organizational and logistic challenges in the very initial phase of the epidemic. Another limitation is the performance of diagnostic tests. The nasopharyngeal swab is currently the procedure most used to obtain samples for molecular testing, but false-negative results are known to occur; thus we may have underestimated the prevalence among HCWs [8] . Limited data are available on the accuracy of serology tests, meaning that the number of probable previous infections may be under-or overestimated [6, 9] .

In conclusion, even in a setting heavily involved in the management of COVID-19 patients, the prevalence of infections among HCWs was reasonably low, presumably a testament to our infection 7 control measures. Our observation that majority of HCWs with evidence of COVID-19 reported no symptoms points to the need for surveillance protocols to identify asymptomatic and potentially infectious HCWs so that they can be removed from the workplace. Currently, molecular testing of nasopharyngeal swabs represents the only means of assessing current infection. Whilst serological tests may have a role in identifying past infections, there remains uncertainty around their diagnostic performance. We suggest that there is a place for periodic testing of HCWs, and that the frequency of testing by molecular methods should be determined on a case-by-case basis, depending on level of exposure, feasibility of screening, and laboratory capacity. The use of serologic test is promising, too, but at moment some uncertainties about their diagnostic performance are still present. Funding source: we declare that no specific funding has been used for this work;

Moreover, we declare that:

• the material included in this paper is original and has not been submitted elsewhere;

• all authors have seen and approved the final manuscript;

• informed consent has been obtained from all HCWs included in the paper. In any case, data have been anonymized and all results are collectively presented. 

Protecting Chinese Healthcare Workers While Combating the 2019 Novel Coronavirus

Occupational risks for COVID-19 infection

Risk Factors of Healthcare Workers with Corona Virus Disease 2019: A Retrospective Cohort Study in a Designated Hospital of Wuhan in China

Coronavirus Disease 2019 (COVID-19) in Italy

Temporal dynamics in viral shedding and transmissibility of COVID-19

Strong associations and moderate predictive value of early symptoms for SARSCoV-2 test positivity among healthcare workers, the Netherlands

Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom

Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures